Johnson & Johnson · NYSE:JNJ

Johnson & Johnson — Proxy Contest (January 2006)

32 slides from Johnson & Johnson's proxy contest presentation, Jan 17, 2006

  1. Slide 1: Company Group Chairman Eric Milledge

    Eric Milledge Company Group Chairman

  2. Slide 2: Founded 1886 in New Brunswick, New Jersey

    Founded 1886 New Brunswick, New Jersey In a Former Wallpaper Factory By three brothers with a dream… that Joseph Lister’s theories about sterilization could save lives in America’s hospitals

  3. Slide 3: World's Most Comprehensive and Broadly Based Health Care Company

    V- & World's Most Co hensive and Broadl ed Han, Cyrg company = A pre ¥: ai

  4. Slide 4: Products, Patients & Customers

    Products Patients & Customers

  5. Slide 5: Operating Companies

    =e Operating Companies ». ~ In ountri [orld Selling Pr in ; vv —_

  6. Slide 6: Global Presence

    Global Presence

  7. Slide 7: Strategic Principles

    Broadly Based in Human Health Care Decentralized Management Manage for the Long Term Ethical Principles Our Credo Strategic Principles • • • • •

  8. Slide 8: Our Credo

    Written by General Robert Wood Johnson, Jr. in the 1940s Visionary and U.S. business leader Among the first to speak openly of a company’s responsibility Our Credo • • •

  9. Slide 9: The Four Tenets of Our Credo

    Customers Employees Community Shareholders Our Credo The Four Tenets • • • •

  10. Slide 10: 2004 Performance Results

    13.1% 18.2% 18.3% Sales Net Earnings Diluted EPS $47.3B $8.5B $2.84 2004 Performance Results

  11. Slide 11: 2004 Sales by Segment

    46.7% Consumer $8.3 Medical Devices & Diagnostics $16.9 Pharmaceuticals $22.1 17.6% 35.7% Total Sales: $47.3 Billion $U.S. Billions 2004 Sales by Segment

  12. Slide 12: 2004 Sales by Geographic Area

    59% Asia, Pacific, Africa $5.8 W. Hemisphere $2.6 Europe $11.1 U.S. $27.8 23% 6% 12% Total Sales: $47.3 Billion $U.S. Billions 2004 Sales by Geographic Area

  13. Slide 13: Historical Performance

    (1) Proforma excluding In-process R&D, taxes on repatriated cash under the AJC Act and other charges and credits 100 +10.6% +11.0% +10.7% 50 +11.1 +11.7 +14.2 20 +10.9 +10.8 +15.6 10 +11.8 +12.3 +16.9 5 +11.6 +11.1 +16.9 1 +13.1 +9.7 +16.8 Reported Operational Net Year Sales Sales Income(1) Historic

  14. Slide 14: Historical Performance: Consecutive Years of Increases

    (1) Proforma excluding In-process R&D, taxes on repatriated cash under the AJC Act and other charges and credits 72 Consecutive years of Sales increases 20 Consecutive years of double digit Earnings increases (1) 42 Consecutive years of Dividend increases Historical Performance • • •

  15. Slide 15: Investment in Research

    $U.S. Billions 9.6% Percent to Sales 11.0% Investment in Research

  16. Slide 16: LifeScan

    €LLIFESCAN

  17. Slide 17: LifeScan Vision

    “Creating a world without limits for people with diabetes” LifeScan Vision

  18. Slide 18: LifeScan At A Glance

    U.S. International Employees 1,600 2,100 Sales Force 400 420 Customer Service 220 70 2004 Sales $1.7B LifeScan At A Glance

  19. Slide 19: Worldwide Glucose Monitoring Market

    Ex U.S. U.S. 5.1 5.7 6.5 8.3 10 .0 Source: LifeScan Estimates, Analyst Reports $ Billions CAGR 8% Worldwide Glucose Monitoring Market

  20. Slide 20: LifeScan Key Products

    Source: International Diabetes Federation LifeScan Key Products

  21. Slide 21: LifeScan is the #1 Manufacturer of Test Strips in the U.S.

    LifeScan is the #1 Manufacturer of Test Strips in the U.S.

  22. Slide 22: LifeScan is #1 Recommended by U.S. Healthcare Professionals

    LifeScan is #1 Recommended by U.S. Healthcare Professionals

  23. Slide 23: LifeScan #1 at U.S. Health Plans

    YTD July 2005 LifeScan #1 at U.S. Health Plans

  24. Slide 24: LifeScan Dollar Sales

    $ Billions LifeScan Dollar Sales

  25. Slide 25: LifeScan Mission

    “To fundamentally change our business from , and transform LifeScan from an episodic monitoring company to a company.” measurement to management true diabetes management LifeScan Mission

  26. Slide 26: Our Strategic Direction

    Continued leadership in Glucose Monitoring Expansion into Insulin Delivery Creation of Diabetes Management solutions Glucose Monitoring • • • Episodic Continuous Diabetes Management Medication Insulin Delivery Our Strategic Direction

  27. Slide 27: Giaek PORAT 1.GsaN

    Giaek PORAT 1.GsaN

  28. Slide 28: Making diabetes management easier

    Making diabetes management easier through product innovation, exceptional customer support and customized education programs.

  29. Slide 29: Advancing Care Together

    Advancing Care Together

  30. Slide 30: LifeScan Sales & Marketing

    Direct to Consumer Marketing Leading in Multi- Cultural Marketing Best-in-Class Customer Support Strong CRM Programs with 3.4M Database LifeScan Sales & Marketing • • • •

  31. Slide 31: Culture For Success

    Extraordinary talent Entrepreneurship – intelligent risk taking Collaboration and team work Passion and sense of urgency Speed, flexibility, agility Flawless execution • • • • • • Culture For Success

  32. Slide 32: The Johnson & Johnson Family

    The Johnson & Johnson Family

Johnson & Johnson — Proxy Contest (January 2006) on 6ix